NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

NCT00557011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: NRP104
DRUG: Adderall XR
DRUG: Placebo

Sponsor

New River Pharmaceuticals